Implantable medical lead including tine markers

• US 8,000,805 B2
• Filed: 10/30/2006
• Issued: 08/16/2011
• Est. Priority Date: 08/31/2001
• Status: Expired due to Term

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Spinelli, Michele, Mamo, George J., Hartle, Steven D., Carlton, Keith R., Swoyer, John M., Gerber, Martin T.
• Primary Examiner(s): Patel; Niketa I
• Assistant Examiner(s): STOKLOSA, JOSEPH A
• Application Number:
  US11/589,407
• Publication Number:
  US 20070050004A1
• Time in Patent Office: 1,751 Days
• Field of Search: 607/116, 607/117, 607/128
• US Class Current: 607/117
• CPC Class Codes: A61N 1/0551 Spinal or peripheral nerve electrodes
• CPC Class Codes: A61N 1/0558 Anchoring or fixation means therefor

Abstract

An implantable medical electrical lead particularly for stimulation of the sacral nerves comprises a lead body extending between a distal end and a proximal end, and the distal end having at least one electrode of an electrode array extending longitudinally from the distal end toward the proximal end. The lead body at its proximal end may be coupled to a pulse generator, additional intermediate wiring, or other stimulation device. A fixation mechanism is formed on or integrally with the lead body proximal to the electrode array that is adapted to be implanted in and engage subcutaneous tissue, particularly muscle tissue, to inhibit axial movement of the lead body and dislodgement of the stimulation electrodes.

Claims

1. An implantable medical lead comprising:

a lead body extending between a proximal end and a distal end;

an electrode disposed proximate to the distal end of the lead body;

a plurality of tine elements extending from the lead body;

a first marker positioned on the lead body between the proximal end and all of the tine elements extending from the lead body; and

a second marker separate from the first marker and positioned on the lead body between the distal end and all of the tine elements extending from the lead body.

2. The implantable medical lead of claim 1, wherein the first and second markers are positioned to indicate a location of the plurality of tine elements.

3. The implantable medical lead of claim 1, wherein the first and second markers each comprise a radiographic imaging marker.

4. The implantable medical lead of claim 1, wherein the first and second markers each comprise a band extending around an outer perimeter of the lead body.

5. The implantable medical lead of claim 1, wherein the plurality of tine elements are positioned between the electrode and the proximal end of the lead body.

6. The implantable medical lead of claim 1, wherein the plurality of tine elements are formed of a flexible implantable grade superelastic alloy.

7. The implantable medical lead of claim 1, wherein the electrode comprises an elongated, flexible electrode adapted to assume a curve when implanted in relation to body tissue.

8. The implantable medical lead of claim 1, wherein the electrode comprises a plurality of stimulation electrodes arranged in an electrode array extending proximally from the distal end of the lead through a distal segment of the lead body adjacent to the distal end of the lead body, and the implantable medical lead further comprises:

a plurality of proximal connector elements formed in a connector array in a proximal segment of the lead body adjacent to the proximal end of the lead body;

a plurality of lead conductors extending between the plurality of connector elements and the plurality of stimulation electrodes; and

the plurality of tine elements formed in a tine element array extending through the proximal segment of the lead between the electrode array and the proximal end of the lead body, each tine element comprising a plurality of flexible tines, each tine having a tine width and thickness and extending through a tine length from an attached tine end to a free tine end, the attached tine end attached to the lead body from a tine attachment site and supporting the tine extending outwardly of the lead body and proximally toward the proximal end of the lead body, whereby the plurality of tines are adapted to be folded inward against the lead body when fitted into and constrained by a lumen of an introducer and deploy outward to engage body tissue when the introducer is withdrawn proximally, wherein each of the tine elements comprises biocompatible plastic.

9. The implantable medical lead of claim 8, wherein the tine attachment sites of the plurality of tine elements are separated longitudinally along the lead body in the tine element array by a distance that is substantially equal to or exceeds the tine length when folded proximally against the lead body so that the tines are not overlapping one another.

10. The implantable medical lead of claim 8, wherein the tine attachment sites of each of the plurality of tine elements are disposed in a common circumference of the lead body, and the tine attachment sites of adjoining tine elements along the lead body are radially offset from one another around the common circumference such that the tine free ends of the tines of each adjacent tine element engage against body tissue at radially and axially separated points along the tine element array.

11. The implantable medical lead of claim 8, wherein tine lengths and tine widths of tines of a first tine element of the plurality of tine elements are configured to enable the tines of first tine element to fold toward the proximal end of the lead body alongside and interleaved with tines of a second tine element of the plurality of tine elements, the second tine element being located closer to the proximal end of the lead body than the first tine element.

12. The implantable medical lead of claim 8, wherein each of the plurality of tine elements include an equal number of tines.

23. The implantable medical lead of claim 1, wherein the second marker comprises a visual and radiographic imaging marker.

24. The implantable medical lead of claim 1, wherein the plurality of tine elements are longitudinally separated along the lead body.

13. An assembly comprising:

an introducer comprising a lumen; and

a lead configured to be introduced into the lumen of the introducer and comprising;

a lead body extending between a proximal end and a distal end;

an electrode disposed proximate to the distal end of the lead body;

a plurality of tine elements extending from the lead body;

a first marker positioned on the lead body between the proximal end and all of the tine elements extending from the lead body; and

a second marker separate from the first marker and positioned on the lead body between the distal end and all of the tine elements extending from the lead body.

14. The assembly of claim 13, wherein the first and second markers are positioned to indicate a location of the plurality of tine elements with respect to the introducer.

15. The assembly of claim 13, wherein the first marker is visible when the plurality of tine elements are deployed from the introducer.

16. The assembly of claim 13, wherein the introducer comprises a third marker to indicate the location of the plurality of tine elements with respect to the introducer.

17. The assembly of claim 13, wherein the first and second markers and at least a portion of the lumen of the introducer are fluoroscopically visible.

18. A method of implanting a medical lead proximate to a stimulation site in a patient, the method comprising:

introducing an introducer into body tissue, the introducer comprising a lumen extending between a lumen proximal end and a lumen distal end;

advancing the medical lead through the lumen of the introducer, the medical lead comprising;

a lead body extending between a proximal end and a distal end;

an electrode disposed proximate to the distal end of the lead body;

a plurality of tine elements extending from the lead body;

a first marker positioned on the lead body between the proximal end and all of the tine elements extending from the lead body; and

a second marker separate from the first marker and positioned on the lead body between the distal end and all of the tine elements extending from the lead body;

positioning the lumen distal end of the lumen proximate to the stimulation site to dispose the electrode in operative relation to body tissue to be stimulated; and

withdrawing the introducer proximally past the first marker on the lead body to release the plurality of tine elements.

19. The method of claim 18, wherein introducing the introducer into body tissue comprises percutaneously introducing the introducer through body tissue.

20. The method of claim 18, wherein each tine element of the plurality of tine elements comprises a plurality of tines, and wherein withdrawing the introducer proximally past the first marker on the lead body successively releases the plurality of tines of each of the plurality of tine elements to deploy the plurality of tines outward to engage body tissue and inhibit axial dislodgement of the electrode.

21. The method of claim 18, wherein the medical lead further comprises a connector element electrically coupled to the electrode, wherein the method further comprises electrically coupling the connector element to an implantable pulse generator.

22. The method of claim 18, and further comprising determining a location of the plurality of tine elements within the lumen of the introducer by locating the first and second markers.